Being aware of suspicious diagnostic indicators can make early. The diagnostic evaluation of multiple myeloma comprises thorough historytaking and physical examination, various laboratory tests including analysis of a 24hour urine sample, a bonemarrow biopsy, and skeletal radiography. There has been remarkable progress made in the diagnosis and treatment of multiple myeloma mm. Monitor for multiple myeloma symptoms and m protein serum and urine every six to 12 months.
Its called multiple myeloma as the cancer often affects several areas of the body, such as the spine, skull, pelvis and ribs. Objective multiple myeloma can pose a diagnostic challenge and this article highlights issues in diagnosis. The diagnosis of multiple myeloma requires increased numbers of. Bone marrow is the spongy tissue at the centre of some bones that produces the bodys blood cells. Updated diagnostic criteria and staging system for multiple myeloma. These current guidelines represent a major revision. The updated criteria for the diagnosis of myeloma represent a paradigm shift in the approach to myeloma. Sometimes, multiple myeloma is found early when a routine blood test shows an abnormally high amount of protein in the blood. Plasma cells are part of the immune system, and their main job is to make large volumes of antibody, to help fight infection. Pdf multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal. Guidelines for the diagnosis and management of multiple. The patient handbook focuses on the questions and decisions that a newly diagnosed patient faces. Complications may include amyloidosis the cause of multiple myeloma.
Multiple myeloma mm, also known as plasma cell myeloma and simple myeloma, is a cancer of plasma cells, a type of white blood cell that normally produces antibodies. Multiple myeloma differential diagnoses medscape reference. Smoldering multiple myeloma is not actually cancer, but a precancerous condition signalling a high risk for blood cancer. Learn more about the symptoms, causes, diagnosis, risk factors, and treatment of multiple myeloma. Multiple myeloma accounts for around 1% of all cancers worldwide and 1015% of all hematological neoplasms. Multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal monoclonal paraprotein and evidence of end organ damage. The differential diagnosis of multiple myeloma usually involves the spectrum of plasma cell proliferative disorders shown in. In 2006 guidelines for the diagnosis and management of multiple myeloma were published smith et al, 2006. Plasma cells produce antibodies that help your body fight infections.
Multiple myeloma the path to diagnosis mymyelomateam. Multiple myeloma, the most common bone malignancy, is occurring with increasing. Multiple myeloma is a type of cancer caused by malignant plasma cells in your bone marrow. Its normal to worry, but try to remember that other health conditions can cause similar symptoms as multiple myeloma. Martin, md, discuss the diagnosis and upfront treatment of a 56yearold man with stage international scoring systemii multiple myeloma. Although multiple myeloma has most likely been present for thousands of years, the first welldocumented case was the second patient described by solly in 1844. Multiple myeloma accounts for 1% of all cancers and approximately 10% of all haematological malignancies. Diagnosis of multiple myeloma canadian cancer society. Diagnosing multiple myeloma in primary care clinician. Sometimes, it might cause vague symptoms that at first seem to be caused by other diseases. Background multiple myeloma is characterised by the proliferation of malignant plasma cells within the bone marrow, which produce an abnormal monoclonal paraprotein and evidence of end organ damage. Some of these problems are discussed in detail elsewhere within uptodate.
It will help you learn medical terms and concepts you may not have encountered before. Learn more about the symptoms, causes, diagnosis, and treatment. Multiple myeloma early detection, diagnosis, and staging. The combination of these three tests has a diagnostic sensitivity of 9798%. Multiple myeloma is the second most common type of blood cancer after leukemia. The guideline has been split into two documents, focussing on the diagnosis and management of multiple myeloma and supportive care in multiple myeloma. Test findings such as cancer cells in the bone marrow, abnormal proteins in the blood, low levels of red blood cells, imaging scans that show tumors, and kidney dysfunction are evidence that doctors use to diagnose myeloma. In germany there are around 6500 new cases of multiple myeloma. Diagnosing multiple myeloma includes blood work, a 24hour urine collection, a bone marrow biopsy, imaging studies such as xrays, mris, pet scans and bone. Multiple myeloma mm is a rare malignant tumor of plasma cells that proliferate and accumulate in bone marrow.
The clinical signs observed are due to neoplastic cells infiltration of the bone. Some early cancers may have signs and symptoms that can be noticed, but that is not always the case. Multiple myeloma is a type of blood cancer that starts in white blood cells called plasma cells, which help your body fight infections. The diagnosis of multiple myeloma requires increased numbers of immature, abnormal, or atypical plasma cells in the bone marrow. Multiple myeloma is diagnosed based on the results of clinical tests. Multiple myeloma is characterized by the uncontrolled proliferation of monoclonal plasma cells in the bone marrow, leading to production of. Systemic treatment should be administered only when organ damage has been diagnosed. Multiple myeloma, also known as myeloma, is a type of bone marrow cancer.
Multiple myeloma mm is a debilitating malignancy that is part of a spectrum of diseases ranging from monoclonal gammopathy of unknown significance mgus to plasma cell. Its important for the healthcare team to rule out other reasons for a health problem before making a diagnosis of multiple myeloma. The nccn guidelines for multiple myeloma provide recommendations for diagnosis, workup, treatment, followup, and supportive care for patients with monoclonal gammopathy of renal significance, solitary plasmacytoma, smoldering myeloma, and multiple myeloma. These updated esmo clinical practice guidelines cover the diagnosis and pathologymolecular biology, staging and risk assessment and response evaluation of multiple myeloma. A physician can make a multiple myeloma diagnosis based on a physical exam, a patients symptoms, and findings from lab work, biopsies, and imaging studies. The median survival of the disease has doubled as a. The following tests are commonly used to rule out or diagnose multiple myeloma. The diagnosis and treatment of multiple myeloma ncbi. International myeloma working group updated criteria for. Plasma cells develop from one type of white blood cell called b lymphocytes and are an important part of the immune system. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Multiple myeloma can pose a diagnostic challenge and this article highlights issues in diagnosis. Multiple myeloma mm is a disease that is primarily treated by hematologists. Read about multiple myeloma prognosis, life expectancy, stages, treatment, diagnosis.
Often, multiple myeloma causes no symptoms until it reaches an advanced stage. Multiple myeloma may be diagnosed sooner in those people than those who did not have mgus or a. The diagnosis of multiple myeloma depends on a variety of different tests, including blood tests, bone marrow tests, and imaging of the bones. As it progresses, bone pain, bleeding, frequent infections, and anemia may occur. Multiple myeloma early detection, diagnosis, and staging 1. Multiple myeloma often is seen in the veteran population, and va providers should be familiar with its diagnosis and treatment so that an appropriate referral can be made. Symptoms and signs include anemia, skin lesions, weakness, and bone fractures. Multiple myeloma is cancer that starts in the bone marrows plasma cells.
Multiple myeloma often is seen in the veteran population, and va providers should be familiar with its diagnosis. Imwg criteria for the diagnosis of mm inl myeloma fn. Consensus guidelines on the diagnosis of multiple myeloma and. Multiple myeloma mm is a plasma cell pc malignancy of terminally differentiated b lymphocytes that is typically associated with the secretion of partial andor. Myeloma is called multiple because it frequently involves multiple areas in the body. Patients with multiple myeloma mm frequently develop complications related to their disease, including hypercalcemia, renal insufficiency, infection, and skeletal lesions, which require specific treatment in addition to therapy directed at the malignant clone. International myeloma working group imwg criteria for the diagnosis of multiple myeloma. Primary care providers play a significant role in the diagnosis of multiple myeloma, a detrimental disease of insidious onset. Multiple myeloma accounts for approximately 10% of hematologic malignancies. Shortly after being diagnosed with multiple myeloma, kathy giusti and her sister karen. Multiple myeloma blood american society of hematology. Abstract multiple myeloma accounts for approximately 10% of hematologic malignancies.
918 1544 929 1389 461 1049 94 516 696 1480 340 1342 827 185 447 1460 612 192 967 1090 378 983 1285 1603 847 1263 1454 282 1293 789 468 525 1087 517 1187 1334 510